119 related articles for article (PubMed ID: 32330017)
1. Discovery of Potent Cyclic Sulfopeptide Chemokine Inhibitors via Reprogrammed Genetic Code mRNA Display.
Johansen-Leete J; Passioura T; Foster SR; Bhusal RP; Ford DJ; Liu M; Jongkees SAK; Suga H; Stone MJ; Payne RJ
J Am Chem Soc; 2020 May; 142(20):9141-9146. PubMed ID: 32330017
[TBL] [Abstract][Full Text] [Related]
2. Structural basis of receptor sulfotyrosine recognition by a CC chemokine: the N-terminal region of CCR3 bound to CCL11/eotaxin-1.
Millard CJ; Ludeman JP; Canals M; Bridgford JL; Hinds MG; Clayton DJ; Christopoulos A; Payne RJ; Stone MJ
Structure; 2014 Nov; 22(11):1571-81. PubMed ID: 25450766
[TBL] [Abstract][Full Text] [Related]
3. Regulation of chemokine recognition by site-specific tyrosine sulfation of receptor peptides.
Simpson LS; Zhu JZ; Widlanski TS; Stone MJ
Chem Biol; 2009 Feb; 16(2):153-61. PubMed ID: 19246006
[TBL] [Abstract][Full Text] [Related]
4. Ontogeny of the eotaxins in human lung.
Haley KJ; Sunday ME; Porrata Y; Kelley C; Twomey A; Shahsafaei A; Galper B; Sonna LA; Lilly CM
Am J Physiol Lung Cell Mol Physiol; 2008 Feb; 294(2):L214-24. PubMed ID: 18055844
[TBL] [Abstract][Full Text] [Related]
5. Tyrosine sulfation influences the chemokine binding selectivity of peptides derived from chemokine receptor CCR3.
Zhu JZ; Millard CJ; Ludeman JP; Simpson LS; Clayton DJ; Payne RJ; Widlanski TS; Stone MJ
Biochemistry; 2011 Mar; 50(9):1524-34. PubMed ID: 21235238
[TBL] [Abstract][Full Text] [Related]
6. Homogeneous sulfopeptides and sulfoproteins: synthetic approaches and applications to characterize the effects of tyrosine sulfation on biochemical function.
Stone MJ; Payne RJ
Acc Chem Res; 2015 Aug; 48(8):2251-61. PubMed ID: 26196117
[TBL] [Abstract][Full Text] [Related]
7. Eotaxin/CCL11 suppresses IL-8/CXCL8 secretion from human dermal microvascular endothelial cells.
Cheng SS; Lukacs NW; Kunkel SL
J Immunol; 2002 Mar; 168(6):2887-94. PubMed ID: 11884459
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-β stimulates the expression of eotaxin/CC chemokine ligand 11 and its promoter activity through binding site for nuclear factor-κβ in airway smooth muscle cells.
Matsukura S; Odaka M; Kurokawa M; Kuga H; Homma T; Takeuchi H; Notomi K; Kokubu F; Kawaguchi M; Schleimer RP; Johnson MW; Adachi M
Clin Exp Allergy; 2010 May; 40(5):763-71. PubMed ID: 20214667
[TBL] [Abstract][Full Text] [Related]
9. Identification of potent, selective non-peptide CC chemokine receptor-3 antagonist that inhibits eotaxin-, eotaxin-2-, and monocyte chemotactic protein-4-induced eosinophil migration.
White JR; Lee JM; Dede K; Imburgia CS; Jurewicz AJ; Chan G; Fornwald JA; Dhanak D; Christmann LT; Darcy MG; Widdowson KL; Foley JJ; Schmidt DB; Sarau HM
J Biol Chem; 2000 Nov; 275(47):36626-31. PubMed ID: 10969084
[TBL] [Abstract][Full Text] [Related]
10. Alanine scanning mutagenesis of the chemokine receptor CCR3 reveals distinct extracellular residues involved in recognition of the eotaxin family of chemokines.
Duchesnes CE; Murphy PM; Williams TJ; Pease JE
Mol Immunol; 2006 Mar; 43(8):1221-31. PubMed ID: 16102831
[TBL] [Abstract][Full Text] [Related]
11. A novel, selective, and orally available antagonist for CC chemokine receptor 3.
Morokata T; Suzuki K; Masunaga Y; Taguchi K; Morihira K; Sato I; Fujii M; Takizawa S; Torii Y; Yamamoto N; Kaneko M; Yamada T; Takahashi K; Shimizu Y
J Pharmacol Exp Ther; 2006 Apr; 317(1):244-50. PubMed ID: 16339911
[TBL] [Abstract][Full Text] [Related]
12. Cloning and functional characterization of a novel human CC chemokine that binds to the CCR3 receptor and activates human eosinophils.
White JR; Imburgia C; Dul E; Appelbaum E; O'Donnell K; O'Shannessy DJ; Brawner M; Fornwald J; Adamou J; Elshourbagy NA; Kaiser K; Foley JJ; Schmidt DB; Johanson K; Macphee C; Moores K; McNulty D; Scott GF; Schleimer RP; Sarau HM
J Leukoc Biol; 1997 Nov; 62(5):667-75. PubMed ID: 9365122
[TBL] [Abstract][Full Text] [Related]
13. The CC chemokine eotaxin (CCL11) is a partial agonist of CC chemokine receptor 2b.
Martinelli R; Sabroe I; LaRosa G; Williams TJ; Pease JE
J Biol Chem; 2001 Nov; 276(46):42957-64. PubMed ID: 11559700
[TBL] [Abstract][Full Text] [Related]
14. Phosphate modulates receptor sulfotyrosine recognition by the chemokine monocyte chemoattractant protein-1 (MCP-1/CCL2).
Ludeman JP; Nazari-Robati M; Wilkinson BL; Huang C; Payne RJ; Stone MJ
Org Biomol Chem; 2015 Feb; 13(7):2162-9. PubMed ID: 25536525
[TBL] [Abstract][Full Text] [Related]
15. Characterization of binding between the chemokine eotaxin and peptides derived from the chemokine receptor CCR3.
Ye J; Kohli LL; Stone MJ
J Biol Chem; 2000 Sep; 275(35):27250-7. PubMed ID: 10859315
[TBL] [Abstract][Full Text] [Related]
16. The CC chemokine eotaxin/CCL11 has a selective profibrogenic effect on human lung fibroblasts.
Puxeddu I; Bader R; Piliponsky AM; Reich R; Levi-Schaffer F; Berkman N
J Allergy Clin Immunol; 2006 Jan; 117(1):103-10. PubMed ID: 16387592
[TBL] [Abstract][Full Text] [Related]
17. The ligands of CXC chemokine receptor 3, I-TAC, Mig, and IP10, are natural antagonists for CCR3.
Loetscher P; Pellegrino A; Gong JH; Mattioli I; Loetscher M; Bardi G; Baggiolini M; Clark-Lewis I
J Biol Chem; 2001 Feb; 276(5):2986-91. PubMed ID: 11110785
[TBL] [Abstract][Full Text] [Related]
18. Airway eosinophil accumulation and eotaxin-2/CCL24 expression following allergen challenge in BALB/c mice.
Ben-Yehuda C; Bader R; Puxeddu I; Levi-Schaffer F; Breuer R; Berkman N
Exp Lung Res; 2008 Oct; 34(8):467-79. PubMed ID: 18850374
[TBL] [Abstract][Full Text] [Related]
19. Functional expression and characterization of macaque C-C chemokine receptor 3 (CCR3) and generation of potent antagonistic anti-macaque CCR3 monoclonal antibodies.
Zhang L; Soares MP; Guan Y; Matheravidathu S; Wnek R; Johnson KE; Meisher A; Iliff SA; Mudgett JS; Springer MS; Daugherty BL
J Biol Chem; 2002 Sep; 277(37):33799-810. PubMed ID: 12101185
[TBL] [Abstract][Full Text] [Related]
20. CCL26/eotaxin-3 is more effective to induce the migration of eosinophils of asthmatics than CCL11/eotaxin-1 and CCL24/eotaxin-2.
Provost V; Larose MC; Langlois A; Rola-Pleszczynski M; Flamand N; Laviolette M
J Leukoc Biol; 2013 Aug; 94(2):213-22. PubMed ID: 23532518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
